| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 7 | |
| #2 | EPO (European Patent Office) | 6 | |
| #3 | Republic of Korea | 6 | |
| #4 | Mexico | 5 | |
| #5 | Canada | 4 | |
| #6 | China | 4 | |
| #7 | Taiwan | 4 | |
| #8 | WIPO (World Intellectual Property Organization) | 4 | |
| #9 | Russian Federation | 2 | |
| #10 | Hong Kong | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Organic fine chemistry | |
| #4 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Heterocyclic compounds | |
| #5 | Climate change mitigation in goods production | |
| #6 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Zhang Lianshan | 26 |
| #2 | Cao Guoqing | 18 |
| #3 | Sun Xing | 14 |
| #4 | Yang Changyong | 13 |
| #5 | Tao Weikang | 13 |
| #6 | Cui Dongbing | 9 |
| #7 | Sun Piaoyang | 9 |
| #8 | Tang Mi | 7 |
| #9 | Guo Yong | 7 |
| #10 | Cui Hua | 6 |
| Publication | Filing date | Title |
|---|---|---|
| WO2018072743A1 | Use of pd-1 antibody conjugated with ido inhibitor in preparing anti-tumor drug | |
| WO2018068758A1 | Medical use of anti-c met antibody-cytotoxic drug conjugate | |
| TW201813667A | Combination use of anti-PD-1 antibody and VEGFR inhibitor in the preparation of a medicament for the treatment of cancer |